These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


383 related items for PubMed ID: 16825392

  • 1. Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis.
    Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Kehagia V, Connett GJ, Bruce KD.
    J Clin Microbiol; 2006 Jul; 44(7):2601-4. PubMed ID: 16825392
    [Abstract] [Full Text] [Related]

  • 2. Molecular analysis of diversity within the genus Pseudomonas in the lungs of cystic fibrosis patients.
    Spasenovski T, Carroll MP, Payne MS, Bruce KD.
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):261-7. PubMed ID: 19216939
    [Abstract] [Full Text] [Related]

  • 3. Bacterial activity in cystic fibrosis lung infections.
    Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Kehagia V, Jones GR, Bruce KD.
    Respir Res; 2005 Jun 01; 6(1):49. PubMed ID: 15929792
    [Abstract] [Full Text] [Related]

  • 4. characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling.
    Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Bruce KD.
    J Clin Microbiol; 2004 Nov 01; 42(11):5176-83. PubMed ID: 15528712
    [Abstract] [Full Text] [Related]

  • 5. Molecular analysis of bacteria in asymptomatic and symptomatic endodontic infections.
    Sakamoto M, Rôças IN, Siqueira JF, Benno Y.
    Oral Microbiol Immunol; 2006 Apr 01; 21(2):112-22. PubMed ID: 16476021
    [Abstract] [Full Text] [Related]

  • 6. Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling.
    Rogers GB, Hart CA, Mason JR, Hughes M, Walshaw MJ, Bruce KD.
    J Clin Microbiol; 2003 Aug 01; 41(8):3548-58. PubMed ID: 12904354
    [Abstract] [Full Text] [Related]

  • 7. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center.
    Petrucca A, Cipriani P, Valenti P, Santapaola D, Cimmino C, Scoarughi GL, Santino I, Stefani S, Sessa R, Nicoletti M.
    Res Microbiol; 2003 Sep 01; 154(7):491-8. PubMed ID: 14499935
    [Abstract] [Full Text] [Related]

  • 8. Novel phylogenetic assignment database for terminal-restriction fragment length polymorphism analysis of human colonic microbiota.
    Matsumoto M, Sakamoto M, Hayashi H, Benno Y.
    J Microbiol Methods; 2005 Jun 01; 61(3):305-19. PubMed ID: 15767007
    [Abstract] [Full Text] [Related]

  • 9. Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections.
    Rogers GB, Stressmann FA, Koller G, Daniels T, Carroll MP, Bruce KD.
    Diagn Microbiol Infect Dis; 2008 Oct 01; 62(2):133-41. PubMed ID: 18692341
    [Abstract] [Full Text] [Related]

  • 10. Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory.
    Botterel F, Angebault C, Cabaret O, Stressmann FA, Costa JM, Wallet F, Wallaert B, Bruce K, Delhaes L.
    Mycopathologia; 2018 Feb 01; 183(1):171-183. PubMed ID: 28766039
    [Abstract] [Full Text] [Related]

  • 11. Identifying pioneer bacterial species responsible for biofouling membrane bioreactors.
    Zhang K, Choi H, Dionysiou DD, Sorial GA, Oerther DB.
    Environ Microbiol; 2006 Mar 01; 8(3):433-40. PubMed ID: 16478450
    [Abstract] [Full Text] [Related]

  • 12. RISA-HPLC analysis of lung bacterial colonizers of cystic fibrosis children.
    Nazaret S, Assade F, Brothier E, Freydière AM, Bellon G, Cournoyer B.
    J Microbiol Methods; 2009 Jan 01; 76(1):58-69. PubMed ID: 18929602
    [Abstract] [Full Text] [Related]

  • 13. PCR-based evidence of bacterial involvement in eyes with suspected intraocular infection.
    Okhravi N, Adamson P, Carroll N, Dunlop A, Matheson MM, Towler HM, Lightman S.
    Invest Ophthalmol Vis Sci; 2000 Oct 01; 41(11):3474-9. PubMed ID: 11006241
    [Abstract] [Full Text] [Related]

  • 14. Molecular analysis of bacterial communities associated with the roots of Douglas fir (Pseudotsuga menziesii) colonized by different ectomycorrhizal fungi.
    Burke DJ, Dunham SM, Kretzer AM.
    FEMS Microbiol Ecol; 2008 Aug 01; 65(2):299-309. PubMed ID: 18459969
    [Abstract] [Full Text] [Related]

  • 15. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories.
    Woo PC, Lau SK, Teng JL, Tse H, Yuen KY.
    Clin Microbiol Infect; 2008 Oct 01; 14(10):908-34. PubMed ID: 18828852
    [Abstract] [Full Text] [Related]

  • 16. Vegetation cover of forest, shrub and pasture strongly influences soil bacterial community structure as revealed by 16S rRNA gene T-RFLP analysis.
    Chim Chan O, Casper P, Sha LQ, Feng ZL, Fu Y, Yang XD, Ulrich A, Zou XM.
    FEMS Microbiol Ecol; 2008 Jun 01; 64(3):449-58. PubMed ID: 18430004
    [Abstract] [Full Text] [Related]

  • 17. Rapid identification of marine bioluminescent bacteria by amplified 16S ribosomal RNA gene restriction analysis.
    Kita-Tsukamoto K, Wada M, Yao K, Kamiya A, Yoshizawa S, Uchiyama N, Kogure K.
    FEMS Microbiol Lett; 2006 Mar 01; 256(2):298-303. PubMed ID: 16499620
    [Abstract] [Full Text] [Related]

  • 18. Identification of bacteria from blood in febrile patients with ulcerative colitis by terminal restriction fragment length polymorphism profile analysis of 16S rRNA gene.
    Harada A, Ohkusa T, Kushima K, Sakamoto M, Benno Y, Beppu K, Shibuya T, Sakamoto N, Watanabe S.
    Scand J Gastroenterol; 2008 Mar 01; 43(4):423-30. PubMed ID: 18365907
    [Abstract] [Full Text] [Related]

  • 19. Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers.
    Stressmann FA, Rogers GB, Klem ER, Lilley AK, Donaldson SH, Daniels TW, Carroll MP, Patel N, Forbes B, Boucher RC, Wolfgang MC, Bruce KD.
    J Clin Microbiol; 2011 Jan 01; 49(1):281-91. PubMed ID: 21068277
    [Abstract] [Full Text] [Related]

  • 20. Molecular typing of the bacterial flora in sputum of cystic fibrosis patients.
    Kolak M, Karpati F, Monstein HJ, Jonasson J.
    Int J Med Microbiol; 2003 Aug 01; 293(4):309-17. PubMed ID: 14503795
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.